Differences between CTAB and chitosan in modifying PLGA nanoparticles for gene therapy

• Main Authors: Doolaanea, Abd Almonem, Mansor, Nur 'Izzati, Mohd Nor, Nurul Hafizah, Mohamed, Farahidah
• Format: Conference or Workshop Item
• Language: English; English
• Published: UKM Kuala Lumpur Campus 2015
• Subjects: RS Pharmacy and materia medica
• Online Access: http://irep.iium.edu.my/46387/4/Monem_CRDDS2015.pdf; http://irep.iium.edu.my/46387/7/46387_Differences_Between_CTAB_Abstract.pdf; http://irep.iium.edu.my/46387/

Poly (D, L-Lactic-co-Glycolic Acid) (PLGA) nanoparticles were modified by adding cetyltrimethylammonium bromide (CTAB) to the aqueous phase (F1) or oil phase (F2), or by low (F3) or medium (F4) molecular weight chitosan. Nanoparticles were characterised for their physicochemical and biological prope...